# Faeth Therapeutics, Inc.: Form 8-K, filed Feb 6, 2023

- Company: [Faeth Therapeutics, Inc.](/companies/fth.md) (CIK 1829802)
- Form: 8-K
- Filed: 2023-02-06
- Accepted by EDGAR: Feb 6, 2023, 07:30 ET
- Period: 2023-01-31
- Accession: 0001193125-23-024891
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1829802/000119312523024891/d449181d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829802/000119312523024891/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829802/000119312523024891/d449181d8k.htm

Filed Feb 6, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-024891. Last ingested by Listed: Nov 3, 2026, 23:17 ET. No prices; not investment advice.